Medicines

  1. Blincyto (blinatumomab)
    Blincyto (blinatumomab)
    by Amgen
    for Leukemia
    €2,880.00
  2. Cabometyx (cabozantinib)
    Cabometyx (cabozantinib)
    by Ipsen Pharma
    for Kidney Cancer
    €5,976.00
  3. Calcort (deflazacort)
    Calcort (deflazacort)
    by Merrell Dow/Henning
    for Duchenne Muscular Dystrophy
    €75.00
  4. Cometriq (cabozantinib)
    Cometriq (cabozantinib)
    by Ipsen Pharma
    for Thyroid Cancer
    €5,844.00
  5. Cotellic (cobimetinib)
    Cotellic (cobimetinib)
    by Roche Registration GmbH
    for Skin Cancer
    €5,970.00
  6. Darzalex (daratumumab)
    Darzalex (daratumumab)
    by Janssen-Cilag International N.V.
    for Multiple Myeloma
    €571.20
  7. Descovy (emtricitabine/tenofovir alafenamide)
    Descovy (emtricitabine/tenofovir alafenamide)
    by Gilead Sciences International Limited
    for HIV/AIDS
    €694.80
  8. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
    €1,299.76
  9. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €114.00
View as Grid List

Items 37-45 of 76

per page
Set Descending Direction